Factors determining household expenditure for tuberculosis and coping strategies in Tajikistan

Tropical Medicine and International Health

Volumn 16, Issue 3, 2011, Pages 307-313

  Ayé, Raffael ^a,b   Wyss, Kaspar ^a,b   Abdualimova, Hanifa ^c   Saidaliev, Sadullo ^d  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c Project Sino   (Tajikistan)

^d Ministry of Health and National TB Program   (Tajikistan)

Author keywords

Direct costs; Economic coping strategies; Former Soviet Union; Household costs of disease

Indexed keywords

ASCORBIC ACID; CYANOCOBALAMIN; GLUCONATE CALCIUM; GLUCOSE; POVIDONE; PYRIDOXINE; THIAMINE; TUBERCULOSTATIC AGENT; VITAMIN B COMPLEX;

DISEASE TREATMENT; HEALTH RISK; HOSPITAL SECTOR; HOUSEHOLD EXPENDITURE; PARSIMONY ANALYSIS; QUESTIONNAIRE SURVEY; REGRESSION ANALYSIS; TUBERCULOSIS;

ADOLESCENT; ADULT; ALOE VERA; ARTICLE; COPING BEHAVIOR; COST OF ILLNESS; FEMALE; FINANCIAL MANAGEMENT; GENDER; HOSPITALIZATION; HOUSEHOLD; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; TAJIKISTAN; THERAPY DELAY;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; COST OF ILLNESS; FEMALE; FINANCING, PERSONAL; HEALTH EXPENDITURES; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PATIENT DROPOUTS; TAJIKISTAN; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

TAJIKISTAN;

EID: 79951733485     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2010.02710.x     Document Type: Article

References (24)

1. Aspler A, Menzies D, Oxlade X et al. (2008) Cost of tuberculosis diagnosis and treatment from the patient perspective in Lusaka, Zambia. The International Journal of Tuberculosis and Lung Disease 12, 928-935.
2. Ayé R, Wyss K, Abdualimova H & Saidaliev S (2010a) Household costs of illness during different phases of tuberculosis treatment in Central Asia: a patient survey in Tajikistan. BMC Public Health 10, 18.
3. Ayé R, Wyss K, Abdualimova H & Saidaliev S (2010b) Patient's site of first access to health system influences length of delay for tuberculosis treatment in Tajikistan. BMC Health Services Research 10, 10.
4. Filmer D & Pritchett L (2001) Estimating wealth effects without expenditure data-or tears: an application to educational enrollments in states of India. Demography 38, 115-132.
5. Floyd K, Wilkinson D & Gilks C (1997) Comparison of cost effectiveness of directly observed treatment (DOT) and conventionally delivered treatment for tuberculosis: experience from rural South Africa. BMJ 315, 1407-1411.
6. Grafen A & Hails R (2002) Modern Statistics for the Life Sciences Oxford University Press, New York.
7. Habib F & Baig L (2006) Cost of DOTS for tuberculous patients. The Journal of the Pakistan Medical Association 56, 207-210.
8. Jackson S, Sleigh A, Wang G-J & Liu X-L (2006) Poverty and the economic effects of TB in rural China. The International Journal of Tuberculosis and Lung Disease 10, 1104-1110.
9. Kamolratanakul P, Sawert H, Kongsin S et al. (1999) Economic impact of tuberculosis at the household level. The International Journal of Tuberculosis and Lung Disease 3, 596-602.
10. Leive A & Xu K (2008) Coping with out-of-pocket health payments: empirical evidence from 15 African countries. Bulletin of the World Health Organanization 86, 849-860.
11. Manca A & Palmer S (2005) Handling missing data in patient-level cost-effectiveness analysis alongside randomised clinical trials. Applied Health Economics and Health Policy 4, 65-75.
12. McIntyre D, Thiede M, Dahlgren G & Whitehead M (2006) What are the economic consequences for households of illness and of paying for health care in low- and middle-income country contexts? Social Science & Medicine 62, 858-865.
13. Mosneaga A, Yurasova E, Zaleskis R & Jakubowiak W (2008) Enabling health systems in tuberculosis control: challenges and opportunities for the former Soviet Union countries. In: Health Systems and the Challenge of Communicable Disease Experiences from Europe and Latin America-European Observatory on Health Systems and Policies Series (eds R Coker, R Atun & M McKee ) Open University Press, New York, pp. 171-192.
14. Obrist B, Iteba N, Lengeler C et al. (2007) Access to health care in contexts of livelihood insecurity: a framework for analysis and action. PLoS Medicine 4, 1584-1588.
15. Russell S (1996) Ability to pay for health care: concepts and evidence. Health Policy and Planning 11, 219-237.
16. Russell S (2004) The economic burden of illness for households in developing countries: a review of studies focusing on malaria, tuberculosis, and human immunodeficiency virus/acquired immunodeficiency syndrome. The American Journal of Tropical Medicine and Hygiene 71(Suppl 2), 147-155.
17. Sauerborn R, Adams A & Hien M (1996) Household strategies to cope with the economic costs of illness. Social Science and Medicine 43, 291-301.
18. Saunderson P (1995) An economic evaluation of alternative programme designs for tuberculosis control in rural Uganda. Social Science and Medicine 40, 1203-1212.
19. Schafer J (1997) Analysis of Incomplete Multivariate Data. Chapman & Hall, London.
20. Thierfelder C, Makowiecka K, Vinichenko T, Ayé R, Edwards P & Wyss K (2008) Management of pulmonary tuberculosis in Tajikistan: which factors determine hospitalisation? Tropical Medicine & International Health 13, 1364-1371.
21. Wei X, Chen J, Chen P et al. (2009) Barriers to TB care for rural-to-urban migrant TB patients in Shanghai: a qualitative study. Tropical Medicine & International Health 14, 754-760.
22. WHO (2003) Treatment of Tuberculosis. Guidelines to National Programmes. WHO, Geneva.
23. WHO (2009) Global Tuberculosis Control: Epidemiology, Strategy, Financing. WHO, Geneva.
24. Wyss K, Kilima P & Lorenz N (2001) Costs of tuberculosis for households and health care providers in Dar es Salaam, Tanzania. Tropical Medicine & International Health 6, 60-68.